Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells

Oncogene

Volumn 25, Issue 8, 2006, Pages 1216-1224

  Ichwan, S J A ^a   Yamada, S ^a   Sumrejkanchanakij, P ^b   Ibrahim Auerkari, E ^c   Eto, K ^a   Ikeda, M A ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Apoptosis; p53; p53 resistance; Phosphorylation; Tumor suppressor

Indexed keywords

MUTANT PROTEIN; PROTEIN NOXA; PROTEIN P53; SERINE; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CARCINOMA CELL; CELL GROWTH; CELL LINE; COLONY FORMATION; CONTROLLED STUDY; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; WILD TYPE;

ADENOVIRIDAE; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; HUMANS; LUNG NEOPLASMS; MOUTH NEOPLASMS; MUTATION; PHOSPHORYLATION; RNA, SMALL INTERFERING; SERINE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644535515     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1209158     Document Type: Article

References (43)

1. Appella E, Anderson CW. (2001). Eur J Biochem 268: 2764-2772.
2. Ashcroft M, Kubbutat MH, Vousden KH. (1999). Mol Cell Biol 19: 1751-1758.
3. Bean LJ, Stark GR. (2001). Oncogene 20: 1076-1084.
4. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G et al. (2003). Cancer Cell 3: 387-402.
5. Bode AM, Dong Z. (2004). Nat Rev Cancer 4: 793-805.
6. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E et al. (1999). EMBO J 18: 6845-6854.
7. Chiarugi A, Moskowitz MA. (2002). Science 297: 200-201.
8. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S et al. (2002). Nat Cell Biol 4: 11-19.
9. de Vries A, Flores ER, Miranda B, Hsieh HM, van Oostrom CT, Sage J et al. (2002). Proc Natl Acad Sci USA 99: 2948-2953.
10. Di Stefano V, Blandino G, Sacchi A, Soddu S, D'Orazi G. (2004). Oncogene 23: 5185-5192.
11. Dohoney KM, Guillerm C, Whiteford C, Elbi C, Lambert PF, Hager GL et al. (2004). Oncogene 23: 49-57.
12. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). Cell 75: 817-825.
13. Harris SL, Levine AJ. (2005). Oncogene 24: 2899-2908.
14. Hofmann TG, Möller A, Sirma H, Zentgraf H, Taya Y, Droge W et al. (2002). Nat Cell Biol 4: 1-10.
15. Jackson MW, Agarwal MK, Agarwal ML, Agarwal A, Stanhope-Baker P, Williams BR et al. (2004). Oncogene 23: 4477-4487.
16. Kapoor M, Hamm R, Yan W, Taya Y, Lozano G. (2000). Oncogene 19: 358-364.
17. Ko LJ, Prives C. (1996). Genes Dev 10: 1054-1072.
18. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA et al. (2000). Nat Genet 25: 47-54.
19. Martinez LA, Naguibneva I, Lehrmann H, Vervisch A, Tchenio T, Lozano G et al. (2002). Proc Natl Acad Sci USA 99: 14849-14854.
20. Mayo LD, Rok Seo Y, Jackson MW, Smith ML, Rivera Guzman JR, Korgaonkar CK et al. (2005). J Biol Chem 280: 25953-25959.
21. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. (2000a). Science 288: 1053-1058.
22. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mon T et al. (2000b). Cell 102: 849-862.
23. Ohtani S, Kagawa S, Tango Y, Umeoka T, Tokunaga N, Tsunemitsu Y et al. (2004). Mol Cancer Ther 3: 93-100.
24. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y et al. (2001). Mol Cell 8: 85-94.
25. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. (2002). Hum Mutat 19: 607-614.
26. Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E, Brady JN. (1998). J Virol 72: 6348-6355.
27. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B. (1996). Genes Dev 10: 1945-1952.
28. Prives C, Hall PA. (1999). J Pathol 187: 112-126.
29. Restle A, Janz C, Wiesmuller L. (2005). Oncogene 24: 4380-4387.
30. Rödicker F, Pützer BM. (2003). Cancer Res 63: 2737-2741.
31. Sakai E, Tsuchida N. (1992). Oncogene 7: 927-933.
32. Shieh SY, Ikeda M, Taya Y, Prives C. (1997). Cell 91: 325-334.
33. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. (1997). Genes Dev 11: 3471-3481.
34. Slee EA, O'Connor DJ, Lu X. (2004). Oncogene 23: 2809-2818.
35. Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L et al. (2000). J Biol Chem 275: 29503-29512.
36. Suganuma T, Kawabata M, Ohshima T, Ikeda MA. (2002). Proc Natl Acad Sci USA 99: 13073-13078.
37. Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y, Eto K, Ikeda MA. (2003). Oncogene 22: 8723-8730.
38. Tamamori-Adachi M, Ito H, Sumrejkanchanakij P, Adachi S, Hiroe M, Shimizu M et al. (2003). Circ Res 92: e12-9.
39. Thompson T, Tovar C, Yang H, Carvajal D, Vu BT, Xu Q et al. (2004). J Biol Chem 279: 53015-53022.
40. Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt Sionov R, Lozano G et al. (1999). EMBO J 18: 1805-1814.
41. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z et al. (2004). Science 303: 844-848.
42. Vogelstein B, Lane D, Levine AJ. (2000). Nature 408: 307-310.
43. Vousden KH, Lu X. (2002). Nat Rev Cancer 2: 594-604.